NeuroBionics
Somerville, US · Founded 2023 · Delaware corporation · 5 known investors
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
Founders & leadership
MA
MJ AntoniniFounder, CEO
ND
Nicki DriscollFounder, CTO
PA
Polina AnikeevaFounder
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$4.2MraisedDec 2025 · 7 investors · Other TechnologyRule 506(b)
▶$4.2MraisedDec 2025 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Marc-Joseph AntoniniExecutive Officer, Director
- Nicolette DriscollExecutive Officer, Director
- Polina AnikeevaDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- Proceeds to insiders
- $540K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Neurotechnology Market Fundraising Deals (2026) – New Market Pitchnewmarketpitch.com · 2026
- NeuroBionics Announces Oversubscribed $10M Seed Round with Second Close Led by Future Ventures | NeuroBionicsneurobionics.io · 2025
- NeuroBionics Secures an Oversubscribed $5M Seed Round to Advance Endovascular Neuromodulation Technology - MedTech Innovatormedtechinnovator.org · 2025
- UF start-up firm receives $6 million in fundinggainesville.com · 2005
- NeuroBionics raises cash, names CEO (Chief Executive Officer):insights.citeline.com · 2005